Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update. More
Articles
Buy Advanced Micro Devices as It Rallies to New Heights
After falling over the past two months, AMD stock is again breaking out and presenting a strong buying opportunity to investors. More
BITO ETF Alert: 10 Things to Know as the First Bitcoin Futures ETF Starts Trading Today
The BITO ETF marks a landmark victory for crypto bulls looking for a Wall Street ETF. However, there is a bit of a drawback as well. More
Lagging Rocket Stock Will Certainly Find Its Stride In Time
RKT stock is rebuilding its momentum but coming back from a deep crater. Rocket will need time to earn investors' trust on Wall Street. More
MVIS Stock Made A Lot of Headlines During EV Mania, But Steer Clear
MVIS stock made a lot of headlines during EV mania, but steer clear. The company is stagnating and deserves less attention. More
Ride the Skies for a 50% Return (or More) with Joby Aviation
JOBY stock just can't seem to get off the ground, but there's plenty of room to fly in the burgeoning sustainable mobility market. More
